Innovations are powering earlier diagnoses, personalised treatment and better surgical outcomes.
Companies already investing in
this opportunity
Investment opportunities in diagnostics and therapeutics to 2030
Diagnostics and therapeutics are transitioning from the “one-size-fits-all” approach. Reductions in the cost of diagnostics and better use of algorithms to develop personalised plans are enabling bespoke solutions. Personalised medicine and therapeutics have long been touted as the future of healthcare. The sector, which is already worth over $2.12 trillion, is projected to reach $5.7 trillion by 2030.
Furthermore, the market for digital surgery technologies, which includes robotics, artificial intelligence (AI), advanced imaging, and connected devices, is projected to grow at an average annual growth rate of over 32 percent. Examples of digital surgery technologies include augmented reality navigation headsets allowing doctors to visualise patients’ 3D anatomy during surgery in real-time. The global digital surgery technologies market size is projected to grow from $0.50 billion in 2021 to $ 5.21 billion by 2030, an annual growth rate of over 32 percent.
Examples of nanotechnology in diagnostics and therapeutics include slow-release drug capsules enabled by new pill coatings. Nanotechnology also enables more targeted drugs covered with specific coatings that bind tighter to the affected site, reducing its negative impact on other parts of the body.
Growth in rapid diagnostics to 2029
Opportunities in personalised medicine sector to 2030
Annual growth rate in digital surgery technologies to 2030.
Technology, media, telecom and electronics have been pioneering in areas such as deploying augmented reality for surgeries and surgical navigation. In personalised treatment, Philips BioTelemetry offers cardiac monitoring medical devices, such as Mobile Cardiac Outpatient Telemetry (MCOT) and Philips BioTel Heart, which is a provider of remote cardiac monitoring diagnostic services.
Epicore Biosystems, in partnership with PepsiCo and Gatorade, has developed the Gx Sweat Patch, a skin-like, wearable microfluidic sensing patch designed to capture sweat and offer real-time insights. When paired with a mobile app, it provides personalised recommendations for athletes to optimally hydrate and refuel after exercise.
